Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Placenta polypeptide preparation method

A placental polypeptide and placenta technology, which are applied to the preparation methods of peptides, chemical instruments and methods, peptides, etc., can solve the problems of low yield of polypeptides, and achieve the effects of simple preparation method, less equipment investment and low production cost.

Active Publication Date: 2016-03-23
GUIZHOU TAIBANG BIOLOGICAL PROD
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Aiming at the problem of low yield of polypeptides obtained in the prior art, the object of the present invention is to provide a method for preparing placental polypeptides to improve the yield of placental polypeptides

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] The placenta without hepatitis B, hepatitis C, AIDS, and syphilis virus is shredded and added to normal saline at a mass ratio of 1:2 for tissue homogenization; the resulting tissue homogenate is mixed with a compound enzyme at a mass ratio of 50:1, and the The complex enzyme is composed of trypsin and papain with a mass ratio of 1:1. It is hydrolyzed for 4 hours at 30°C and pH 5, and the centrifuge is collected by centrifugation at 5000r / min. The collected centrifugate is used as the pre-extraction aqueous phase. Hexanol and petroleum ether with a volume ratio of 1:3 are the organic phase, wherein the volume ratio of the pre-extracted organic phase and the aqueous phase is 2:1, and AOT and Span-60 with a mass ratio of 2:1 are used as a mixed surfactant. Extract at 40°C for 15 minutes, use 2mol / L KCl solution as the stripping aqueous phase, wherein the volume ratio of the post-extracted organic phase to the KCl solution aqueous phase is 2:1, strip at 35°C for 30 minutes,...

Embodiment 2

[0023] The placenta without hepatitis B, hepatitis C, AIDS, and syphilis virus is shredded and added to normal saline at a mass ratio of 1:2.5 for tissue homogenization; the resulting tissue homogenate is mixed with a compound enzyme at a mass ratio of 55:1, and the The compound enzyme is composed of five kinds of trypsin, pepsin, papain, bromelain and carboxypeptidase of the same quality. It is hydrolyzed at 35°C and pH 6 for 4.5h, centrifuged at 5000r / min to collect the centrifugate, and the collected The centrifuge liquid is used as the pre-extraction aqueous phase, and the hexanol and sherwood oil of 1:4 volume ratio are organic phases, wherein the organic phase and the aqueous phase volume ratio of pre-extraction are 2.5:1, with the AOT of 2.5:1 mass ratio and division Pan-60 is a mixed surfactant, extracted at 42°C for 16 minutes, using 2mol / L KCl solution as the stripping aqueous phase, wherein the volume ratio of the post-extracted organic phase to the KCl solution aque...

Embodiment 3

[0025] After the placenta without hepatitis B, hepatitis C, AIDS, and syphilis virus is shredded, add physiological saline in a mass ratio of 1:3 to carry out tissue homogenization; the resulting tissue homogenate is mixed with papain in a mass ratio of 60:1, and the ℃, pH 9 conditions of enzymatic hydrolysis for 5h, centrifugation at 5000r / min to collect the centrifugate, the collected centrifugate as the pre-extraction aqueous phase, with 1:5 volume ratio of hexanol and petroleum ether as the organic phase, of which the pre-extracted The volume ratio of the organic phase to the aqueous phase is 3:1, AOT and Span-60 with a mass ratio of 3:1 are used as mixed surfactants, extracted at 45°C for 20 minutes, and 2mol / L KCl solution is used as the back-extracted aqueous phase, The volume ratio of the post-extracted organic phase to the KCl solution aqueous phase is 3:1, back-extracted at 40°C for 40 minutes, and the crude extract of placental polypeptide and protease is obtained af...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a bioactivator preparation method, in particular to a placenta polypeptide preparation method. The placenta polypeptide preparation method comprises the steps of cutting a placenta into pieces, and adding normal saline into the cut placenta for tissue homogenate; mixing the obtained product with protease for enzymatic hydrolysis, and performing centrifugation and collecting centrifugate; performing extraction through reverse micelles to produce placental polypeptides and crude protease extract, subjecting the crude protease extract to ultrafiltration, collecting ultrafiltrate, and drying the ultrafiltrate to produce the placenta polypeptides. The preparation method is simple, production cost is low, equipment investment is little, and large-scale production is facilitated.

Description

technical field [0001] The invention relates to a preparation method of biologically active substances, in particular to a preparation method of placental polypeptide. Background technique [0002] The placenta contains a variety of hormones and enzymes for treating diseases, as well as physiologically active peptides for disease prevention, fitness and beauty, cell growth factors and other substances. Therefore, the results of modern placental preparation research are not only used for disease treatment, but also widely used in health care and beauty field. Physiologically active peptides refer to biologically active peptides. These peptides are as small as dipeptides with only 2 amino acids, and can also be complex long-chain or cyclic peptides. They play an important role in the regulation of cell physiology and metabolic functions. [0003] Currently, biologically active peptides can be prepared by ultrafiltration or enzymatic hydrolysis. For example, a patent document...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12P21/06C07K1/36C07K1/34C12N9/48
CPCC07K1/145C07K1/34C07K1/36C12N9/48C12P21/06
Inventor 杨刚钟正晓李祥蒋志鸿王华班凯
Owner GUIZHOU TAIBANG BIOLOGICAL PROD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com